Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

09.04.2018

2 Am J Surg
5 BMC Cancer
1 Breast Cancer
1 Breast Cancer (Dove Med Press)
5 Breast Cancer Res Treat
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Clin Breast Cancer
2 Clin Cancer Res
1 Eur J Cancer
6 Int J Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
2 JAMA
2 Lancet Oncol
2 Nat Rev Cancer
2 Nature
1 Oncogene
4 Oncol Rep
6 PLoS One
1 Radiology



    Am J Surg

  1. MASSIMINO K
    Discussion of: "Pre-surgical chemotherapy for breast cancer may be associated with improved outcome".
    Am J Surg. 2018 Mar 20. pii: S0002-9610(17)31659.
    >> Share

  2. JOHNSON N
    Discussion of: Routine shave margins are not necessary in early stage breast cancer treated with breast conserving surgery.
    Am J Surg. 2018 Mar 20. pii: S0002-9610(18)30404.
    >> Share


    BMC Cancer

  3. HILLER L, Dunn JA, Loi S, Vallier AL, et al
    Adjuvant trastuzumab duration trials in HER2 positive breast cancer - what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results.
    BMC Cancer. 2018;18:391.
    >> Share

  4. LIU Y, Du Y, Hu X, Zhao L, et al
    Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer.
    BMC Cancer. 2018;18:367.
    >> Share

  5. HUNG CH, Chen FM, Lin YC, Tsai ML, et al
    Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer.
    BMC Cancer. 2018;18:366.
    >> Share

  6. PHI XA, Tagliafico A, Houssami N, Greuter MJW, et al
    Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis.
    BMC Cancer. 2018;18:380.
    >> Share

  7. VAN DER WAAL D, Verbeek ALM, Broeders MJM
    Breast density and breast cancer-specific survival by detection mode.
    BMC Cancer. 2018;18:386.
    >> Share


    Breast Cancer

  8. IWASE M, Sawaki M, Hattori M, Yoshimura A, et al
    Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
    Breast Cancer. 2018 Apr 4. pii: 10.1007/s12282-018-0856.
    >> Share


    Breast Cancer (Dove Med Press)

  9. LIANG Y, Mafuvadze B, Besch-Williford C, Hyder SM, et al
    A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.
    Breast Cancer (Dove Med Press). 2018;10:53-67.
    >> Share


    Breast Cancer Res Treat

  10. CHECK DK, Chawla N, Kwan ML, Pinheiro L, et al
    Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions.
    Breast Cancer Res Treat. 2018 Apr 5. pii: 10.1007/s10549-018-4776.
    >> Share

  11. SCHWARTZ MD, Peshkin BN, Isaacs C, Willey S, et al
    Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
    Breast Cancer Res Treat. 2018 Apr 2. pii: 10.1007/s10549-018-4773.
    >> Share

  12. GHILLI M, Mariniello MD, Scatena C, Dosa L, et al
    Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.
    Breast Cancer Res Treat. 2018 Apr 3. pii: 10.1007/s10549-018-4772.
    >> Share

  13. RAU KM, Ou-Yang F, Chao TC, Kuo YL, et al
    Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan.
    Breast Cancer Res Treat. 2018 Apr 5. pii: 10.1007/s10549-018-4778.
    >> Share

  14. PETROSSIAN K, Nguyen D, Lo C, Kanaya N, et al
    Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer.
    Breast Cancer Res Treat. 2018 Apr 5. pii: 10.1007/s10549-018-4779.
    >> Share


    Cancer

  15. SCOTT JM, Iyengar NM, Nilsen TS, Michalski M, et al
    Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31368.
    >> Share

  16. OLAGUNJU TO, Liu Y, Liang LJ, Stomber JM, et al
    Disparities in the survivorship experience among Latina survivors of breast cancer.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31342.
    >> Share


    Cancer Epidemiol Biomarkers Prev

  17. TANG GH, Satkunam M, Pond GR, Steinberg GR, et al
    Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2018 Apr 4. pii: 1055-9965.EPI-17-0936.
    >> Share


    Cancer Lett

  18. ZANOTTO-FILHO A, Rajamanickam S, Loranc E, Masamsetti P, et al
    Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells.
    Cancer Lett. 2018 Mar 30. pii: S0304-3835(18)30240.
    >> Share


    Clin Breast Cancer

  19. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
    Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
    >> Share


    Clin Cancer Res

  20. RUGO HS, Cortes J, Awada A, O'Shaughnessey J, et al
    Change in topoisomerase 1 (Top1) positive circulating tumor cells impacts overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol.
    Clin Cancer Res. 2018 Apr 4. pii: 1078-0432.CCR-17-3059.
    >> Share

  21. LOIBL S, Weber K, Huober J, Krappmann K, et al
    Risk assessment after neoadjuvant chemotherapy in luminal breast cancer using a clinico-molecular predictor.
    Clin Cancer Res. 2018 Apr 4. pii: 1078-0432.CCR-17-2947.
    >> Share


    Eur J Cancer

  22. PLOQUIN A, Pistilli B, Tresch E, Frenel JS, et al
    5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study.
    Eur J Cancer. 2018;95:30-37.
    >> Share


    Int J Oncol

  23. COLIN C, Meyer M, Cerella C, Kleinclauss A, et al
    Biotinylation enhances the anticancer effects of 15dPGJ2 against breast cancer cells.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4338.
    >> Share

  24. XIONG DD, Chen H, He RQ, Lan AH, et al
    MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4339.
    >> Share

  25. ZHAO Y, Onda K, Yuan B, Tanaka S, et al
    Arsenic disulfideinduced apoptosis and its potential mechanism in two and threedimensionally cultured human breast cancer MCF7 cells.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4357.
    >> Share

  26. LI Y, Zhang Y, Liu X, Wang M, et al
    Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Int J Oncol. 2018 Mar 23. doi: 10.3892/ijo.2018.4332.
    >> Share

  27. ZHAO FQ, Misra Y, Li DB, Wadsworth MP, et al
    Differential expression of Oct3/4 in human breast cancer and normal tissues.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4341.
    >> Share

  28. BUSCHMANN D, Gonzalez R, Kirchner B, Mazzone C, et al
    Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4336.
    >> Share


    J Clin Oncol

  29. REINER AS, Sisti J, John EM, Lynch CF, et al
    Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
    J Clin Oncol. 2018 Apr 5:JCO2017773424. doi: 10.1200/JCO.2017.77.3424.
    >> Share


    J Natl Cancer Inst

  30. MATIKAS A, Foukakis T, Bergh J
    RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018 Mar 29. pii: 4956469. doi: 10.1093.
    >> Share


    JAMA

  31. PEACHMAN RR
    Weighing the Risks and Benefits of Hormonal Contraception.
    JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
    >> Share

  32. KATZ SJ, Jagsi R, Morrow M
    Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
    JAMA. 2018;319:1091-1092.
    >> Share


    Lancet Oncol

  33. METCALFE K, Akbari MR, Narod SA
    Genetic testing for young women with breast cancer.
    Lancet Oncol. 2018;19:e182.
    >> Share

  34. ECCLES DM, Copson ER
    Genetic testing for young women with breast cancer - Authors' reply.
    Lancet Oncol. 2018;19:e183.
    >> Share


    Nat Rev Cancer

  35. HARJES U
    Breast cancer: External communication.
    Nat Rev Cancer. 2018 Apr 3. pii: nrc.2018.30. doi: 10.1038/nrc.2018.
    >> Share

  36. BRADLEY CA
    Breast cancer: Obesity - tipping the scales of resistance.
    Nat Rev Cancer. 2018 Apr 6. pii: nrc.2018.31. doi: 10.1038/nrc.2018.
    >> Share


    Nature

  37. KNOTT SRV, Wagenblast E, Khan S, Kim SY, et al
    Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer.
    Nature. 2018;556:135.
    >> Share

  38. DASGUPTA S, Rajapakshe K, Zhu B, Nikolai BC, et al
    Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
    Nature. 2018 Apr 3. pii: 10.1038/s41586-018-0018.
    >> Share


    Oncogene

  39. SUN L, Xu X, Chen Y, Zhou Y, et al
    Rab34 regulates adhesion, migration, and invasion of breast cancer cells.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0202.
    >> Share


    Oncol Rep

  40. LIN CC, Lo MC, Moody RR, Stevers NO, et al
    Doxycycline targets aldehyde dehydrogenasepositive breast cancer stem cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6337.
    >> Share

  41. SHEN Y, Zhong J, Liu J, Liu K, et al
    Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-alpha36.
    Oncol Rep. 2018 Apr 2. doi: 10.3892/or.2018.6350.
    >> Share

  42. LUO T, Yan Y, He Q, Ma X, et al
    miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6353.
    >> Share

  43. LEON-GALICIA I, Diaz-Chavez J, Albino-Sanchez ME, Garcia-Villa E, et al
    Resveratrol decreases Rad51 expression and sensitizes cisplatinresistant MCF7 breast cancer cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6336.
    >> Share


    PLoS One

  44. HORIBATA S, Rice EJ, Zheng H, Mukai C, et al
    A bi-stable feedback loop between GDNF, EGR1, and ERalpha contribute to endocrine resistant breast cancer.
    PLoS One. 2018;13:e0194522.
    >> Share

  45. LUCHSINGER C, Aguilar M, Burgos PV, Ehrenfeld P, et al
    Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    PLoS One. 2018;13:e0195401.
    >> Share

  46. HAN Q, Chen R, Wang F, Chen S, et al
    Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    PLoS One. 2018;13:e0192888.
    >> Share

  47. BAMBHROLIYA A, Van Wyhe RD, Kumar S, Debeb BG, et al
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    PLoS One. 2018;13:e0192689.
    >> Share

  48. LUENGO-GIL G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, et al
    Angiogenic role of miR-20a in breast cancer.
    PLoS One. 2018;13:e0194638.
    >> Share

  49. HORIBATA S, Rice EJ, Mukai C, Marks BA, et al
    ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    PLoS One. 2018;13:e0194023.
    >> Share


    Radiology

  50. BURNSIDE ES, Vulkan D, Blanks RG, Duffy SW, et al
    Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.
    Radiology. 2018 Apr 3:171539. doi: 10.1148/radiol.2018171539.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016